These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 722960)

  • 21. Changes in biliary lipid and biliary bile acid composition in patients after administration of ursodeoxycholic acid.
    Makino I; Nakagawa S
    J Lipid Res; 1978 Aug; 19(6):723-8. PubMed ID: 690512
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biliary lipid metabolism in gallstone disease and during gallstone dissolution treatment.
    Nilsell K
    Acta Chir Scand Suppl; 1985; 528():1-38. PubMed ID: 3866449
    [No Abstract]   [Full Text] [Related]  

  • 23. Medical treatment of biliary duct stones: effect of ursodeoxycholic acid administration.
    Salvioli G; Salati R; Lugli R; Zanni C
    Gut; 1983 Jul; 24(7):609-14. PubMed ID: 6345281
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bile acid feeding and hepatic sterol metabolism: effect of deoxycholic acid.
    Carulli N; Ponz de Leon M; Zironi F; Iori R; Loria P
    Gastroenterology; 1980 Oct; 79(4):637-41. PubMed ID: 7409383
    [No Abstract]   [Full Text] [Related]  

  • 25. Dissolution of cholesterol gallstones by ursodeoxycholic acid.
    Nakagawa S; Makino I; Ishizaki T; Dohi I
    Lancet; 1977 Aug; 2(8034):367-9. PubMed ID: 70585
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ursodeoxycholic acid therapy and biliary lipids--a dose-response study.
    Bateson MC; Ross PE; Murison J; Saunders JH; Bouchier IA
    Gut; 1980 Apr; 21(4):305-10. PubMed ID: 7429292
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gallstone recurrence after oral bile acid dissolution treatment.
    Borum M; Albert M; Fromm H
    Gastroenterology; 1990 Jun; 98(6):1723-4. PubMed ID: 2338211
    [No Abstract]   [Full Text] [Related]  

  • 28. [Cholelithiasis treated with chenodeoxycholic acid. An analysis of changes in the pattern of bile acids (author's transl)].
    Hrabák P; Dosková M; Soucková E
    Cas Lek Cesk; 1981 Jul; 120(27):817-23. PubMed ID: 7261002
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of ursodeoxycholic acid and chenodeoxycholic acid on cholesterol and bile acid metabolism.
    Tint GS; Salen G; Shefer S
    Gastroenterology; 1986 Oct; 91(4):1007-18. PubMed ID: 3527851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical studies on cheno- and ursodeoxycholic acid treatment for gallstone dissolution.
    Iwamura K
    Hepatogastroenterology; 1980 Feb; 27(1):26-34. PubMed ID: 7203354
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mesophase formation during cholesterol gallstone dissolution in human bile: effect of bile acid composition.
    Su CC; Higuchi WI; Gilmore IT; Danzinger RG; Hofmann AF
    J Pharm Sci; 1984 Aug; 73(8):1160-1. PubMed ID: 6491925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of ursodeoxycholic acid on gallbladder contraction and cholecystokinin release in gallstone patients and normal subjects.
    van Erpecum KJ; van Berge Henegouwen GP; Stolk MF; Hopman WP; Jansen JB; Lamers CB
    Gastroenterology; 1990 Sep; 99(3):836-42. PubMed ID: 2199291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Change of bile composition in man after administration of cholestyramine (a gallstone dissolving agent in hamsters).
    van der Linden W; Nakayama F
    Acta Chir Scand; 1969; 135(5):433-8. PubMed ID: 5357672
    [No Abstract]   [Full Text] [Related]  

  • 34. Changes in serum bile acids during treatment with chenodiol or ursodiol for dissolution of cholesterol gallstones.
    Nowak M; Panveliwalla D; Pertsemlidis D
    Mt Sinai J Med; 1983; 50(3):240-4. PubMed ID: 6604868
    [No Abstract]   [Full Text] [Related]  

  • 35. [Correlation of biliary cholesterol, phospholipids and bile acid compositions and the development of cholesterol cholelithiasis in mice].
    Yamahara J; Chisaka T; Sawada T; Fujimura H
    Nihon Yakurigaku Zasshi; 1983 Sep; 82(3):171-80. PubMed ID: 6662416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of conjugated bile acids in bile by high-pressure liquid chromatography. II. Clinical application in bile of patients with gallstones.
    Maruyama K
    Nihon Geka Hokan; 1982 Jan; 51(1):14-43. PubMed ID: 7092460
    [No Abstract]   [Full Text] [Related]  

  • 37. [Medicamentous gallstone dissolution (author's transl)].
    Leuschner U
    Schweiz Rundsch Med Prax; 1982 Mar; 71(10):405-7. PubMed ID: 7088882
    [No Abstract]   [Full Text] [Related]  

  • 38. Ursodeoxycholic acid: a review of its pharmacological properties and therapeutic efficacy.
    Ward A; Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1984 Feb; 27(2):95-131. PubMed ID: 6365507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differing effects of ursodeoxycholic or chenodeoxycholic acid on biliary cholesterol saturation and bile acid metabolism in man. A dose-response study.
    Thistle JL; Larusso NF; Hofmann AF; Turcotte J; Carlson GL; Ott BJ
    Dig Dis Sci; 1982 Feb; 27(2):161-8. PubMed ID: 7075411
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bile acids substituted in the 6 position prevent cholesterol gallstone formation in the hamster.
    Cohen BI; Matoba N; Mosbach EH; Ayyad N; Hakam K; Suh SO; McSherry CK
    Gastroenterology; 1990 Feb; 98(2):397-405. PubMed ID: 2295395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.